Literature DB >> 4007031

Inhibition of lymphocyte response to mitogens by dipyridamole: preliminary findings.

I Melamed, A Aviram, A Rubinstein, V Zakuth, G Peresechensky, Z Spirer.   

Abstract

It has been recently noted that dipyridamole (DP) may be involved in certain immunological reactions, in addition to its antiplatelet action. In the present investigation the mitogenic response of human lymphocytes from three groups of subjects to 3 different lectins was examined. In both the experimental group treated over a short period and in the controls a highly significant decrease in the mean lymphocyte response to all 3 mitogens was noted following 3 days of DP administration. The response remained low after an additional 3 days of treatment. Discontinuation of drug administration was followed by a significant increase in response to two mitogens, concanavalin A (Con A) and pokeweed mitogen (PWM). The response to phytohaemagglutinin (PHA) extent only increased to a small, non-significant. No change in the mean mitogenic response was detected in the group undergoing long-term treatment. The mechanism by which DP alters lymphocyte activity is as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007031     DOI: 10.1007/bf00543321

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Letter: Dipyridamole: increase of human leucocytes migration in agarose and modification of human lymphocytes reactivity.

Authors:  E G Coeugniet; ? B Søeberg
Journal:  Thromb Diath Haemorrh       Date:  1975-06-30

2.  Mitogenic responsiveness and monocyte-lymphocyte interaction of early and late rosette-forming cell populations of human peripheral blood lymphocytes.

Authors:  N Taniguchi; T Miyawaki; N Moriya; T Nagaoki; E Kato
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

3.  A set of surface proteins common to the circulating human platelet and lymphocyte.

Authors:  M J Tanner; D H Boxer; J Cumming; J Verrier-Jones
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

4.  Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.

Authors:  J Amir; S Krauss
Journal:  Blood       Date:  1973-07       Impact factor: 22.113

5.  Thrombocyte migration inhibitory activity of human lymphocytes stimulated with concanavalin-A antagonized by dipyridamole and acetylsalicylic-acid.

Authors:  E Coeugniet
Journal:  Thromb Haemost       Date:  1978-04-30       Impact factor: 5.249

6.  Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals.

Authors:  V Gurewich; B Lipinski; R Wetmore
Journal:  Blood       Date:  1975-04       Impact factor: 22.113

7.  Adenosine deaminase inhibition for immunosuppression.

Authors:  M M Chassin; M A Chirigos; D G Johns; R H Adamson
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

8.  Effects of dipyridamole on human blood lymphocytes.

Authors:  J Pazdur; K Krzystyniak; M Kopeć
Journal:  Biochem Pharmacol       Date:  1980-09-15       Impact factor: 5.858

Review 9.  The role of de novo purine synthesis in lymphocyte transformation.

Authors:  A C Allison; T Hovi; R W Watts; A D Webster
Journal:  Ciba Found Symp       Date:  1977

10.  Platelet function studies in coronary artery disease. X. Effect of dipyridamole.

Authors:  J Mehta; P Mehta; C J Pepine; C R Conti
Journal:  Am J Cardiol       Date:  1981-05       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.